,
Litton, Edward
Baker, Stuart
Erber, Wendy N.
Farmer, Shannon
Ferrier, Janet
French, Craig
Gummer, Joel
Hawkins, David
Higgins, Alisa
Hofmann, Axel
De Keulenaer, Bart
McMorrow, Julie
Olynyk, John K.
Richards, Toby
Towler, Simon
Trengove, Robert
Webb, Steve
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial
https://doi.org/10.1007/s00134-016-4465-6
Funding for this research was provided by:
State Health Research Advisory Council
Article History
Received: 20 May 2016
Accepted: 27 July 2016
First Online: 30 September 2016
Compliance with ethical standards
:
: Dr. Richards reports grants from the UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA), the Australian National Health and Medical Research Council (NHMRC) and the UK National Institute of Academic Anaesthesia (NIAA)/British Journal of Anaesthesia (BJA)/Association of Cardiothoracic Anaesthetists (ACTA)/Vascular Anaesthesia Society of Great Britain and Ireland (VASGBI); grants, personal fees and non-financial support from Pharmocosmos, Vifor Pharma, Acelity and the Stroke Association; grants from Mason Medical Research Foundation and University College Hospital (UCH) League of Friends; grants and non-financial support from Libresse/Bodyform, outside the submitted work. TR is a regular speaker at national and international conferences on anaemia, blood transfusion, wound healing and vascular diseases for which he has received expenses for travel, accommodation and sundries. TR is a director of The Iron Clinic Ltd and director of Veincare London Ltd. TR is also the vascular lead for 18-Week Wait Ltd. Shannon Farmer reports personal fees from Thieme Stuttgart, Germany, and Elsevier Science USA, non-financial support from the National Blood Authority (Australia), the Medical Society for Blood Management and non-financial support from The Health Round Table, outside the submitted work. Dr. Hofmann reports personal fees from Vifor Pharma AG and TEM International GmbH, outside the submitted work. The other authors declare no conflict of interest.